Indivior PLC announced on June 24, 2025, the appointment of Tony Kingsley to its Board of Directors as an Independent Non-Executive Director, effective July 1, 2025. This appointment further strengthens the company's governance structure.
Mr. Kingsley's appointment was made pursuant to Indivior's relationship agreement with affiliates of Oaktree Capital Management, L.P., who supported his addition to the Board. This reflects ongoing collaboration with key shareholders.
The addition of Mr. Kingsley is expected to contribute to the strategic oversight and direction of the company as it continues to focus on its core business of opioid use disorder treatments.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.